Developer docs
API playgroundTry for free, no card

Search company profiles

ABLE Human Motion

Full company profile

uuid0003gi8

Namestring
ABLE Human Motion
Legal namestring
ABLE Human Motion S.L.
Company typeenum
Private
Founded yearint
2018
Short descriptiontext

ABLE Human Motion is a Barcelona-based medical device company that designs, manufactures, and sells the CE-marked ABLE Exoskeleton — a 17 kg powered hip-knee robotic exoskeleton — to hospitals and rehabilitation centers in the European Union for clinical gait rehabilitation of patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
robotic exoskeletons, medical devices, neurorehabilitation equipment, gait rehabilitation, rehabilitation robotics
Industry3 codes
PRIMARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Robotic Exoskeletons
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Exoskeleton Device Sales
TypeHardware Sales
Description

Sale of the ABLE Exoskeleton as a medical device to hospitals and rehabilitation centers in the European Union. The device is CE-marked under MDR regulation. Pricing is positioned as accessible and cost-effective compared to traditional exoskeletons (~200k EUR).

ablehumanmotion.com
2Training and Implementation Services
TypeProfessional Services
Description

Training programs provided to therapists with device purchase. Formation is necessary to operate the device, with a training program provided upon purchase.

ablehumanmotion.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Others
Pricing details1 tier
1Standard clinical exoskeleton for neurorehabilitation
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

One-time purchase model for clinical use. Priced significantly below traditional exoskeletons (~200k EUR). Includes training program with purchase. ABLE Exoskeleton is the first lightweight, easy-to-use, and affordable exoskeleton on the market according to company claims.

ablehumanmotion.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1ABLE Care
Description

Mobile application for personalized and data-driven rehabilitation therapy, syncing wirelessly with the ABLE Exoskeleton.

ablehumanmotion.com
Core offering1 text field

ABLE Human Motion designs, manufactures, and commercializes a CE-marked lightweight (17 kg) hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation. The device assists patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases to stand, walk, turn, and sit during therapy sessions, and is sold to hospitals and rehabilitation centers across the European Union alongside the ABLE Care cloud-connected mobile application.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 500+ persons with neurological impairments walked 2,000,000+ steps with ABLE Exoskeleton
+5 more records
Product overview1 text field

ABLE Human Motion's product portfolio centers on the ABLE Exoskeleton — a CE-marked, hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation, designed and manufactured in Barcelona. The device is complemented by the ABLE Care mobile application, which provides a cloud-connected digital layer for session data management, real-time metrics, and personalized therapy tracking. A home-use version of the exoskeleton is in development, planned for a 2026 launch.

Product and service1 record
1ABLE Exoskeleton
CategoryMedical Robotic Exoskeletons - Neurorehabilitation
Description

Lightweight (17 kg), adjustable hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation, designed and manufactured in Barcelona. It assists patients with spinal cord injury (C5–L5), multiple sclerosis (EDSS up to 8.5), and neuromuscular diseases to stand up, walk, turn, and sit down. Features include quick donning in under 6 minutes, three step-initiation modes (manual button, center-of-mass weight shift, dynamic pelvic motion), active turning assistance, adjustable per-joint and per-gait-phase motor assistance, 2 batteries delivering 2–4 hours continuous use, and integration with the ABLE Care mobile application for data-driven therapy. CE-marked under EU MDR 2017/745 for use by hospitals and rehabilitation centers. Suitable for patients 150–190 cm tall and up to 100 kg.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distributor for BENELUX region (Belgium, Netherlands, Luxembourg). Handles commercialization of ABLE Exoskeleton in these markets. Contact: Mutsaardstraat 47, B-9550 Herzele, Belgium.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distributor for Portugal. Commercializes ABLE Exoskeleton in the Portuguese market since September 2025. Contact: Calle Vilar de Donas 19, 28050 Madrid, Spain.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distributor for Romania. Handles commercialization of ABLE Exoskeleton in the Romanian market. Contact: Calea Turzii 189A, Cluj-Napoca, Romania.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distributor for Poland. Handles commercialization of ABLE Exoskeleton in the Polish market. Contact: Ligocka Street 17A, 44-105 Gliwice, Poland.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Official distributor for Italy. Handles commercialization of ABLE Exoskeleton in the Italian market. Contact: Via Pietro di Pietramellara 12, 20158 Milano MI, Italy.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner from which ABLE Human Motion originated in October 2018. The Biomechanical Engineering Laboratory conducted research that led to the company's formation. Professor Josep M. Font (UPC) is a co-founder. UPC provides ongoing R&D collaboration.

7Institut Guttmann
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading neurorehabilitation hospital in Barcelona that served as a clinical validation partner. Conducted clinical trials and provided feedback for product co-creation. Physiotherapist Mark Wright and rehabilitation physician Prof. José Estay have collaborated on clinical studies and testimonials.

ablehumanmotion.com
8Hospital Asepeyo Barcelona
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner that led the 2022 clinical trial in safety and functioning of the ABLE Exoskeleton (hip-knee version). Physiotherapist Mariona Tolrà contributed to product development and provided clinical feedback.

ablehumanmotion.com
9Hospital Universitario de Heidelberg
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Leading German neurorehabilitation center that collaborated on clinical trials for the ABLE Exoskeleton. Prof. Dr.-Ing. Rüdiger Rupp, Director of Experimental Neurorehabilitation Department, served as clinical advisor and provided testimonials.

ablehumanmotion.com
10Hospital Sint Maartenskliniek (Netherlands)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dutch hospital that conducted clinical research on sensory feedback in exoskeleton use with ABLE. Researchers Prof. Noël Keijsers and Eline Zwijgers studied the device's effectiveness and provided feedback for improvements. Collaboration began in July 2022.

ablehumanmotion.com
Strategic tierMinorTypeOthers
Description

Member of IISART, an association dedicated to advancing and promoting healthcare technology in rehabilitation. CEO Alfons Carnicero serves on the IISART Steering Committee. IISART represents developers, manufacturers, and marketers of medical devices in robotics and advanced healthcare technology.

Strategic tierMinorTypeOthers
Description

Member of the Spanish Federation of Medical Technology Companies, which aggregates manufacturers, importers, and distributors of technologies and health products in Spain.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based developer of EksoGT and other lower-extremity robotic exoskeletons for clinical neurorehabilitation and stroke/spinal cord injury gait training. Direct competitor in CE/FDA-regulated hospital exoskeletons targeting the same indications as ABLE.

TypeDirect peer
Description

Israeli/US public company offering the ReWalk Personal and ReStore soft exoskeleton systems for SCI and stroke rehabilitation. Competes with ABLE in both clinical gait training and (eventually) home/ambulatory use of powered exoskeletons.

TypeDirect peer
Description

Japanese developer of the HAL (Hybrid Assistive Limb) lower-extremity exoskeleton used in hospitals for neurorehabilitation. Competes with ABLE in clinical gait training for SCI, stroke, and neuromuscular diseases.

TypeBroad incumbent
Description

Global German incumbent in prosthetics, orthotics, and rehabilitation technology with a broader portfolio including orthotic exoskeletal devices. Competes indirectly in rehab clinics via established distribution and wider product breadth.

TypeBroad incumbent
Description

US industrial conglomerate whose Indego lower-limb exoskeleton is sold for clinical and personal use. Comparable on product and customer segment, though Parker is a much larger diversified industrial player.

6Hocoma
TypeBroad incumbent
Description

Swiss-based global leader in robotic rehabilitation (Lokomat, Armeo, Erigo). Sells to the same hospital/rehab center buyer as ABLE but offers a much broader portfolio of robotic and sensor-based rehab devices.

7Bionik Laboratories
TypeDirect peer
Description

Canadian public company developing the ARKE lower-body exoskeleton for clinical gait rehabilitation. Closely comparable niche peer in size, indication focus, and clinical-only go-to-market.

TypeEmerging player
Description

Chinese rehabilitation robotics company with lower-limb exoskeleton products (e.g., Fourier X1/X2) used in hospitals in Asia and expanding into Europe. Comparable on product category and clinical use case, with stronger manufacturing scale.

TypeEmerging player
Description

Italian developer of wearable exoskeletons for industrial and clinical applications. Comparable on underlying robotic exoskeleton technology and European clinical customer base, though with broader industrial focus.

TypeEmerging player
Description

Hong Kong-based developer of robotic rehabilitation devices including upper-limb systems. Adjacent competitor in the robotic rehab device category, sharing the same clinical hospital buyer and regulatory pathway.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ABLE Human Motion

Medical Robotic Exoskeletonsablehumanmotion.com

ABLE Human Motion is a Barcelona-based medical device company that designs, manufactures, and sells the CE-marked ABLE Exoskeleton — a 17 kg powered hip-knee robotic exoskeleton — to hospitals and rehabilitation centers in the European Union for clinical gait rehabilitation of patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases.

ABLE Human Motion firmographics

Firmographics
Name
ABLE Human Motion
Legal name
ABLE Human Motion S.L.
Website
https://ablehumanmotion.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
ABLE Human Motion is a Barcelona-based medical device company that designs, manufactures, and sells the CE-marked ABLE Exoskeleton — a 17 kg powered hip-knee robotic exoskeleton — to hospitals and rehabilitation centers in the European Union for clinical gait rehabilitation of patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases.
Ownership category
akta.pro rank

ABLE Human Motion industry classification

Industry
Product category
Medical Robotic Exoskeletons
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHAMAG
Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Rehabilitation & Mobility Aids (DME)
SECONDARYHSADAIAN
Prosthetics/Orthotics Rehab & Amputee Rehabilitation
Home & Personal Services/Fitness, Wellness & Personal Training/Physical Therapy, Rehabilitation & Corrective Exercise

Keywords

  • Robotic exoskeletons
  • Medical devices
  • Neurorehabilitation equipment
  • Gait rehabilitation
  • Rehabilitation robotics

Where ABLE Human Motion is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

ABLE Human Motion business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Others

Revenue model

  1. Exoskeleton Device Sales: Sale of the ABLE Exoskeleton as a medical device to hospitals and rehabilitation centers in the European Union. The device is CE-marked under MDR regulation. Pricing is positioned as accessible and cost-effective compared to traditional exoskeletons (~200k EUR).
  2. Training and Implementation Services: Training programs provided to therapists with device purchase. Formation is necessary to operate the device, with a training program provided upon purchase.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractStandard clinical exoskeleton for neurorehabilitation

Go-to-market motion1 record

Distribution channels7 records

Marketing channels6 records

ABLE Human Motion product offering

Product offering

Core offering

ABLE Human Motion designs, manufactures, and commercializes a CE-marked lightweight (17 kg) hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation. The device assists patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases to stand, walk, turn, and sit during therapy sessions, and is sold to hospitals and rehabilitation centers across the European Union alongside the ABLE Care cloud-connected mobile application.

Product overview

ABLE Human Motion's product portfolio centers on the ABLE Exoskeleton — a CE-marked, hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation, designed and manufactured in Barcelona. The device is complemented by the ABLE Care mobile application, which provides a cloud-connected digital layer for session data management, real-time metrics, and personalized therapy tracking. A home-use version of the exoskeleton is in development, planned for a 2026 launch.

Differentiator

Problem solved

Functional benefit

Brands

  • ABLE Care: Mobile application for personalized and data-driven rehabilitation therapy, syncing wirelessly with the ABLE Exoskeleton.

Products and services

  • ABLE Exoskeleton Lightweight (17 kg), adjustable hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation, designed and manufactured in Barcelona. It assists patients with spinal cord injury (C5–L5), multiple sclerosis (EDSS up to 8.5), and neuromuscular diseases to stand up, walk, turn, and sit down. Features include quick donning in under 6 minutes, three step-initiation modes (manual button, center-of-mass weight shift, dynamic pelvic motion), active turning assistance, adjustable per-joint and per-gait-phase motor assistance, 2 batteries delivering 2–4 hours continuous use, and integration with the ABLE Care mobile application for data-driven therapy. CE-marked under EU MDR 2017/745 for use by hospitals and rehabilitation centers. Suitable for patients 150–190 cm tall and up to 100 kg.

Quantifiable outcome

  • 500+ persons with neurological impairments walked 2,000,000+ steps with ABLE Exoskeleton
  • +5 more outcomes

Companies that use ABLE Human Motion

Customer profile

Named customers6 records

Segments2 records

Ideal customer profiles2 records

ABLE Human Motion technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

ABLE Human Motion partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • BeMedicocoreChannel Partner/ Reseller/ DistributorOfficial distributor for BENELUX region (Belgium, Netherlands, Luxembourg). Handles commercialization of ABLE Exoskeleton in these markets. Contact: Mutsaardstraat 47, B-9550 Herzele, Belgium.
  • Bayber Health S.L.coreChannel Partner/ Reseller/ DistributorOfficial distributor for Portugal. Commercializes ABLE Exoskeleton in the Portuguese market since September 2025. Contact: Calle Vilar de Donas 19, 28050 Madrid, Spain.
  • PHYSIOMED Aparatura Medicala S.R.L.coreChannel Partner/ Reseller/ DistributorOfficial distributor for Romania. Handles commercialization of ABLE Exoskeleton in the Romanian market. Contact: Calea Turzii 189A, Cluj-Napoca, Romania.
  • Skyfi Sp. z o. o.coreChannel Partner/ Reseller/ DistributorOfficial distributor for Poland. Handles commercialization of ABLE Exoskeleton in the Polish market. Contact: Ligocka Street 17A, 44-105 Gliwice, Poland.
  • Roboticlever srlcoreChannel Partner/ Reseller/ DistributorOfficial distributor for Italy. Handles commercialization of ABLE Exoskeleton in the Italian market. Contact: Via Pietro di Pietramellara 12, 20158 Milano MI, Italy.
  • Universitat Politècnica de Catalunya (UPC)coreStrategic or Co-development PartnerAcademic partner from which ABLE Human Motion originated in October 2018. The Biomechanical Engineering Laboratory conducted research that led to the company's formation. Professor Josep M. Font (UPC) is a co-founder. UPC provides ongoing R&D collaboration.
  • Institut GuttmanncoreStrategic or Co-development PartnerLeading neurorehabilitation hospital in Barcelona that served as a clinical validation partner. Conducted clinical trials and provided feedback for product co-creation. Physiotherapist Mark Wright and rehabilitation physician Prof. José Estay have collaborated on clinical studies and testimonials.
  • Hospital Asepeyo BarcelonacoreStrategic or Co-development PartnerClinical partner that led the 2022 clinical trial in safety and functioning of the ABLE Exoskeleton (hip-knee version). Physiotherapist Mariona Tolrà contributed to product development and provided clinical feedback.
  • Hospital Universitario de HeidelbergcoreStrategic or Co-development PartnerLeading German neurorehabilitation center that collaborated on clinical trials for the ABLE Exoskeleton. Prof. Dr.-Ing. Rüdiger Rupp, Director of Experimental Neurorehabilitation Department, served as clinical advisor and provided testimonials.
  • Hospital Sint Maartenskliniek (Netherlands)coreStrategic or Co-development PartnerDutch hospital that conducted clinical research on sensory feedback in exoskeleton use with ABLE. Researchers Prof. Noël Keijsers and Eline Zwijgers studied the device's effectiveness and provided feedback for improvements. Collaboration began in July 2022.
  • IISART (International Industrial Society in Advanced Rehabilitation Technology)minorOthersMember of IISART, an association dedicated to advancing and promoting healthcare technology in rehabilitation. CEO Alfons Carnicero serves on the IISART Steering Committee. IISART represents developers, manufacturers, and marketers of medical devices in robotics and advanced healthcare technology.
  • FENIN (Federación Española de Empresas de Tecnología Sanitaria)minorOthersMember of the Spanish Federation of Medical Technology Companies, which aggregates manufacturers, importers, and distributors of technologies and health products in Spain.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

ABLE Human Motion competitors and assessment

Company assessment

Direct peers

  • Ekso Bionics: US-based developer of EksoGT and other lower-extremity robotic exoskeletons for clinical neurorehabilitation and stroke/spinal cord injury gait training. Direct competitor in CE/FDA-regulated hospital exoskeletons targeting the same indications as ABLE.
  • ReWalk Robotics: Israeli/US public company offering the ReWalk Personal and ReStore soft exoskeleton systems for SCI and stroke rehabilitation. Competes with ABLE in both clinical gait training and (eventually) home/ambulatory use of powered exoskeletons.
  • Cyberdyne: Japanese developer of the HAL (Hybrid Assistive Limb) lower-extremity exoskeleton used in hospitals for neurorehabilitation. Competes with ABLE in clinical gait training for SCI, stroke, and neuromuscular diseases.
  • Bionik Laboratories: Canadian public company developing the ARKE lower-body exoskeleton for clinical gait rehabilitation. Closely comparable niche peer in size, indication focus, and clinical-only go-to-market.

Broad incumbents

  • Ottobock: Global German incumbent in prosthetics, orthotics, and rehabilitation technology with a broader portfolio including orthotic exoskeletal devices. Competes indirectly in rehab clinics via established distribution and wider product breadth.
  • Parker Hannifin (Indego): US industrial conglomerate whose Indego lower-limb exoskeleton is sold for clinical and personal use. Comparable on product and customer segment, though Parker is a much larger diversified industrial player.
  • Hocoma: Swiss-based global leader in robotic rehabilitation (Lokomat, Armeo, Erigo). Sells to the same hospital/rehab center buyer as ABLE but offers a much broader portfolio of robotic and sensor-based rehab devices.

Emerging players

  • Fourier Intelligence: Chinese rehabilitation robotics company with lower-limb exoskeleton products (e.g., Fourier X1/X2) used in hospitals in Asia and expanding into Europe. Comparable on product category and clinical use case, with stronger manufacturing scale.
  • Wearable Robotics: Italian developer of wearable exoskeletons for industrial and clinical applications. Comparable on underlying robotic exoskeleton technology and European clinical customer base, though with broader industrial focus.
  • Rehab-Robotics (Hand of Hope): Hong Kong-based developer of robotic rehabilitation devices including upper-limb systems. Adjacent competitor in the robotic rehab device category, sharing the same clinical hospital buyer and regulatory pathway.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

ABLE Human Motion social profiles

Digital presence

ABLE Human Motion compliance and trust

Trust signal

Compliance2 records

ABLE Human Motion financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ABLE Human Motion leadership team

Management profile

Number of profiles

Profiles4 records

ABLE Human Motion funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ABLE Human Motion M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ABLE Human Motion

What does ABLE Human Motion do?

ABLE Human Motion designs, manufactures, and commercializes a CE-marked lightweight (17 kg) hip-and-knee powered robotic exoskeleton for clinical neurorehabilitation. The device assists patients with spinal cord injury, multiple sclerosis, and neuromuscular diseases to stand, walk, turn, and sit during therapy sessions, and is sold to hospitals and rehabilitation centers across the European Union alongside the ABLE Care cloud-connected mobile application.

Is ABLE Human Motion a public or private company?

ABLE Human Motion is a private company. It is classified as venture growth investor backed and is currently operating.

When was ABLE Human Motion founded?

ABLE Human Motion was founded in 2018. It employs 11 to 50 people.

Where is ABLE Human Motion based?

ABLE Human Motion is headquartered in Barcelona, Spain, in the Europe region.

How does ABLE Human Motion make money?

Two revenue lines are on record. Exoskeleton Device Sales are the primary driver. The others are training and Implementation Services.

Who are ABLE Human Motion's main competitors?

Direct peers on record are Ekso Bionics, ReWalk Robotics, Cyberdyne and Bionik Laboratories. Broad incumbents are Ottobock, Parker Hannifin (Indego) and Hocoma. Emerging players are Fourier Intelligence, Wearable Robotics and Rehab-Robotics (Hand of Hope).

Does ABLE Human Motion have an API?

No public API is recorded for ABLE Human Motion.

What industry is ABLE Human Motion in?

ABLE Human Motion's product category is Medical Robotic Exoskeletons. Its primary akta.pro industry code is HDAAAIAC, Healthcare & Assistive Robotics, with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cyprus MailEurope still breeds bold innovators, despite its competitiveness worriesThe EIT Innovation Awards 2025 took place in Budapest on November 25, bringing together Europe's innovation community for a day of pitches, prizes and policy debate organised by the European Institute of Innovation and Technology (EIT). EIT leadership highlighted that Europe excels at research but lags in turning ideas into market-ready products, while announcing a new Knowledge and Innovation Community focused on water and a Memorandum of Understanding with the Government of Malta allocating at least €30 million to support Maltese startups by 2028. Awards were presented to innovators including German startup reLi Energy, Spanish company ABLE Human Motion and Italian team AI Automated Industrial Analytics.EithealthRobots in medicine: The robotics start-ups making a difference in healthcareEIT Health highlights several start-ups, including ABLE Human Motion, Akara, and Somnox, that are developing robotics solutions to transform healthcare through rehabilitation, operational efficiency, and sleep improvement. These companies have received support through funding, accelerators, and partnerships with major hospitals like Tartu University Hospital to validate their technologies in clinical settings.EithealthRobots in medicine: The robotics start-ups making a difference in healthcareEIT Health-supported start-ups ABLE Human Motion, Akara, and Somnox are utilizing robotics to transform healthcare sectors including rehabilitation, hospital automation, and sleep therapy. ABLE Human Motion recently secured a CE Mark for its exoskeleton following clinical trials in Germany and Spain, while Akara has partnered with Tartu University Hospital for clinical trials of its AI-powered operational efficiency systems. The article outlines the broader applications of medical robotics in diagnostics, surgery, pharmacy automation, and logistics, highlighting advantages like precision and efficiency alongside challenges such as high costs and ethical concerns.150secRegenerative robots: six medtech startups helping people healSix European medtech startups are developing robotic and AI-based devices to aid rehabilitation and disease monitoring. ABLE Human Motion raised €750,000 for exoskeletons, while Tendo's sleeve helps patients with gripping limitations. The startups aim to make accessible, low-cost solutions for patients with mobility or neurological impairments.Medicaldesignandoutsourcing7 medtech ideas out of EuropeSeven medtech ideas from the CRAASH Barcelona program were presented, including an exoskeleton, electronic glasses, and a stroke analysis tool. The program, run by EIT Health, awarded a 6,000 euro first prize to Able Human Motion and a 3,000 euro finalist prize to Biel Smartgaze.